Zilucoplan Side Effects
Medically reviewed by Drugs.com. Last updated on Jul 19, 2023.
Applies to zilucoplan: subcutaneous solution.
Warning
You may get infections more easily, even serious or fatal infections. Call your doctor if you have flu symptoms, cough, night sweats, neck stiffness, confusion, or vision problems.
You will need to receive certain vaccinations before you start using zilucoplan.
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
You may get infections more easily, even serious or fatal infections. Call your doctor right away if you have signs of infection such as:
-
fever, chills, sore throat;
-
mouth sores, red or swollen gums;
-
pale skin, easy bruising, unusual bleeding;
-
chest discomfort, wheezing, dry cough or hack, rapid weight loss;
-
signs of meningitis--headache, neck stiffness, increased sensitivity to light, nausea, vomiting, confusion, drowsiness; or
-
pancreatitis--severe pain in your upper stomach spreading to your back, nausea and vomiting.
Common side effects may include:
-
pain, bruising, swelling, or irritation where the medicine was injected;
-
cold symptoms such as stuffy nose, sneezing, sore throat; or
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to zilucoplan: subcutaneous solution.
General
The most common adverse effects in at least 10% of patients were injection site reactions, upper respiratory tract infections, and diarrhea.[Ref]
Gastrointestinal
Very common (10% or more): Diarrhea (11%)
Common (1% to 10%): Nausea, vomiting
Frequency not reported: Pancreatic events[Ref]
Pancreatic events included pancreatitis and pancreatic cysts.[Ref]
Genitourinary
Common (1% to 10%): Urinary tract infection[Ref]
Local
Very common (10% or more): Injection site reactions (29%)
Other
Common (1% to 10%): Increased lipase, increased amylase
Frequency not reported: Meningococcal infection, transient elevations of blood eosinophils[Ref]
Respiratory
Very common (10% or more): Upper respiratory tract infections (14%)[Ref]
More about zilucoplan
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
References
1. Product Information. Zilbrysq (zilucoplan). UCB Pharma Inc. 2023.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.